# Angela Rao

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/angela-rao/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,387 |
| Field | HIV/AIDS drug development and treatment |
| h-index | 26 |
| i10-index | 44 |
| Last Known Institution | University of Tasmania |
| OpenAlex ID | https://openalex.org/A5083444346 |
| ORCID iD | 0000-0002-7904-5556 |
| Works | 138 |

## Researcher papers

- [Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents](https://scholariq.org/papers/discovery-of-2-3-diaryl-1-3-thiazolidin-4-ones-as-potent-anti-hiv-1-agents/)
- [Design, Synthesis, Structure−Activity Relationships, and Molecular Modeling Studies of 2,3-Diaryl-1,3-thiazolidin-4-ones as Potent Anti-HIV Agents](https://scholariq.org/papers/design-synthesis-structure-activity-relationships-and-molecular-modeling-studies/)
- [Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors](https://scholariq.org/papers/pharmacophore-based-design-of-hiv-1-integrase-strand-transfer-inhibitors/)
- [The prevalence and impact of depression and anxiety in cardiac rehabilitation: A longitudinal cohort study](https://scholariq.org/papers/the-prevalence-and-impact-of-depression-and-anxiety-in-cardiac-rehabilitation-a/)
- [Design, Synthesis, and 3D QSAR of Novel Potent and Selective Aromatase Inhibitors](https://scholariq.org/papers/design-synthesis-and-3d-qsar-of-novel-potent-and-selective-aromatase-inhibitors/)
- [Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo\[3,4-a\]benzimidazole structurally-related 1,2-substituted benzimidazoles](https://scholariq.org/papers/synthesis-and-anti-hiv-activity-of-1-2-6-difluorophenyl-1h-3h-thiazolo-3-4-a/)
- [2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors](https://scholariq.org/papers/2-2-6-dihalophenyl-3-pyrimidin-2-yl-1-3-thiazolidin-4-ones-as-non-nucleoside-hiv/)
- [Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-(thi)one derivatives](https://scholariq.org/papers/synthesis-and-anti-hiv-activity-of-2-3-diaryl-1-3-thiazolidin-4-thi-one/)
- [Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones](https://scholariq.org/papers/synthesis-and-anti-hiv-activity-of-2-3-diaryl-1-3-thiazolidin-4-ones/)
- [Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains](https://scholariq.org/papers/discovery-of-novel-benzimidazolones-as-potent-non-nucleoside-reverse/)
- [Feasibility and acceptability of “LiCPain” pilot randomised controlled trial of continuous subcutaneous infusion of lidocaine or placebo for people with neuropathic cancer pain: a qualitative study of patient and carer perceptions and experiences](https://scholariq.org/papers/feasibility-and-acceptability-of-licpain-pilot-randomised-controlled-trial-of/)

## Researcher topics

- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Click Chemistry and Applications](https://scholariq.org/topics/click-chemistry-and-applications/)
- [Synthesis and Characterization of Heterocyclic Compounds](https://scholariq.org/topics/synthesis-and-characterization-of-heterocyclic-compounds/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)

## Researcher university

- [University of Tasmania](https://scholariq.org/institutions/university-of-tasmania/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.